Skip to content

CONMED CNMD Change in Other Liabilities

Change in Other Liabilities at other companies

Johnson & Johnson logo
Johnson & JohnsonJNJ
-$629M+90.3%
Vericel logo
VericelVCEL
$4K-99.6%
IAR
Integra LifeSciencesIART
$369K-73.4%
Merit Medical Systems logo
Merit Medical SystemsMMSI
$15M+2,146%
Intuitive Surgical logo
Intuitive SurgicalISRG
$30.7M+126%

Other financials

Income statement

See full
Revenue$317.0M-1.3%
Gross profit$183.4M+3.2%
Operating income$25.4M+59.3%
Net income$13.8M+129%
EPS (diluted)$0.45+137%

Balance sheet

See full
Cash & equivalents$35.0M-1.3%
Total debt$862.6M-3.6%
Total equity$1.0B+4.1%
Total assets$2.3B+0.8%

Cash flow

See full
Operating cash flow$13.5M-67.6%
CapEx$2.9M-23.5%
Free cash flow$10.6M-72.0%

Valuation

See full
Market cap$1.04B-35.6%
Enterprise value$1.87B-24.5%
P/E19×+5.4×
P/S0.8×-0.5×

Profitability

See full
Gross margin55.2%-1.0pp
Operating margin8.2%-5.6pp
Net margin4%-5.0pp
FCF margin9%-3.5pp

Returns & leverage

See full
Return on equity5.5%-7.5pp
Debt / equity0.8×-0.1×
Current ratio2.3×0.0×

Where this comes from

Reported directly by CONMED in its filing.

Tagged under the XBRL concept us-gaap:IncreaseDecreaseInOtherOperatingLiabilities.

The official record: CONMED’s 10-Q, filed April 30, 2026, on SEC EDGAR. View the filing →

Ask your AI about CONMED's change in other liabilities.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is CONMED's change in other liabilities?
CONMED (CNMD) reported change in other liabilities of -$2.76M in Q1 2026.
How has CONMED's change in other liabilities changed year-over-year?
CONMED's change in other liabilities decreased by 127.5% year-over-year, from $10.05M to -$2.76M.
What is the long-term trend for CONMED's change in other liabilities?
Over 2 years (2022 to 2025), CONMED's change in other liabilities has grown at a 391.9% compound annual growth rate (CAGR), from -$256K to $6.19M.
What does change in other liabilities mean?
Change in miscellaneous liabilities affecting operating cash flow.